Skip to main content
SupplementScience
UC-II (Undenatured Type II Collagen) supplement
Collagen Protein

UC-II (Undenatured Type II Collagen): Benefits, Dosage, Forms & Research

Collagen Protein

This content is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement. Full disclaimer

TL;DR — Quick Answer

UC-II at 40mg daily reduces joint pain and improves function through immune-mediated oral tolerance, where the body learns to stop attacking its own cartilage. A head-to-head trial showed UC-II outperformed 1,500mg glucosamine + 1,200mg chondroitin for knee OA symptoms.

Key Facts

What it is
Undenatured (native) type II collagen from chicken cartilage that works through immune-mediated oral tolerance
Primary benefits
  • Reduces joint pain via oral immune tolerance
  • Improves joint flexibility and mobility
  • Outperforms glucosamine + chondroitin in trials
  • Effective at very low doses (40mg/day)
Typical dosage
40mg daily on an empty stomach
Evidence level
Moderate
Safety profile
Generally Safe

What the Research Says

UC-II has a compelling evidence base centered on its unique oral tolerance mechanism. The Lugo et al. (2016) head-to-head trial was pivotal, showing UC-II 40mg daily outperformed the gold-standard combination of glucosamine 1,500mg + chondroitin 1,200mg for all WOMAC subscales over 180 days. Crowley et al. (2009) established efficacy vs. placebo in knee OA. The mechanism is distinct from other joint supplements: UC-II does not provide structural building blocks but rather trains the immune system to stop inflammatory attacks on type II collagen in cartilage. This requires the collagen to remain undenatured (native structure intact) and to be taken on an empty stomach to preserve its structure through the GI tract to Peyer patches.

Benefits of UC-II (Undenatured Type II Collagen)

  • Superior to glucosamine + chondroitin — Lugo et al. (2016, n=191) found UC-II 40mg outperformed G+C (1,500mg+1,200mg) for WOMAC pain, stiffness, and physical function over 180 days
  • Knee OA symptom reduction — Crowley et al. (2009, n=52) showed UC-II 40mg daily significantly reduced VAS pain scores by 40% vs. placebo in knee OA patients over 90 days
  • Exercise-related joint support — Lugo et al. (2013, n=55) demonstrated UC-II improved knee extension range of motion and extended time to joint pain during exercise in healthy volunteers
  • Immune modulation — UC-II works through oral tolerance in Peyer patches of the gut, training T-regulatory cells to suppress immune attacks on type II collagen in joints
  • Convenient low dose — only 40mg daily required compared to multi-gram doses of other joint supplements, improving compliance
Did you know?

UC-II has a compelling evidence base centered on its unique oral tolerance mechanism.

Forms of UC-II (Undenatured Type II Collagen)

FormBioavailabilityBest For
UC-II (Patented)N/A (works via oral tolerance, not systemic absorption)Joint pain — the only form with clinical trial support; must remain undenatured

Dosage Recommendations

General recommendation: 40mg UC-II daily, taken on an empty stomach (important for oral tolerance mechanism)

Timing: Take on an empty stomach, ideally before bed or first thing in the morning — food may denature the collagen and reduce efficacy

Dosage by Condition

ConditionRecommended DoseEvidence
Knee osteoarthritis40mg daily on empty stomachModerate
Exercise-related joint discomfort40mg daily on empty stomachModerate
General joint support40mg daily on empty stomachModerate

Upper limit: 40mg daily is the studied dose; higher doses have not shown additional benefit and may impair oral tolerance

Side Effects and Safety

Safety profile: Generally Safe

Potential Side Effects

  • Very well tolerated at 40mg daily
  • Mild GI discomfort (rare)
  • Headache (rare)
  • No serious adverse events reported in clinical trials

Drug & Supplement Interactions

  • Immunosuppressant drugs — UC-II works through immune modulation; theoretical interaction with immunosuppressive therapy
  • No significant interactions reported in clinical studies
Check UC-II (Undenatured Type II Collagen) interactions with other supplements →
BenefitsDosage GuideSide EffectsTypes & FormsResearchFAQ

Related Conditions

Joint Pain

Related Supplements

Collagen Type IIGlucosamineChondroitinHyaluronic Acid

Frequently Asked Questions

How is UC-II different from regular collagen supplements?

UC-II is undenatured (native) type II collagen that works through immune-mediated oral tolerance, not as a structural building block. Regular hydrolyzed collagen is broken down into amino acids and peptides for structural support at doses of 5-10g daily. UC-II works at just 40mg because its intact triple-helix structure interacts with the gut immune system to reduce autoimmune cartilage destruction.

Why must UC-II be taken on an empty stomach?

The oral tolerance mechanism requires the undenatured collagen structure to reach Peyer patches in the small intestine intact. Stomach acid and digestive enzymes activated by food can denature the collagen, destroying its native structure and eliminating the immune-modulatory effect. Taking it on an empty stomach with water minimizes this degradation.

Can I take UC-II together with glucosamine or chondroitin?

Yes. UC-II works through a completely different mechanism (immune modulation) than glucosamine and chondroitin (structural support). They are complementary rather than redundant. However, take UC-II separately on an empty stomach while glucosamine and chondroitin can be taken with meals.

References

  1. (). Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. Journal of the International Society of Sports Nutrition. DOI
  2. (). Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study. Nutrition Journal. DOI
  3. (). Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. International Journal of Medical Sciences. DOI